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ABSTRACT
The protein inference problem represents a major challenge in shotgun proteomics. In this
article, we describe a novel Bayesian approach to address this challenge by incorporating the
predicted peptide detectabilities as the prior probabilities of peptide identification. We pro-
pose a rigorious probabilistic model for protein inference and provide practical algoritmic
solutions to this problem.We used a complex synthetic proteinmixture to test ourmethod and
obtained promising results.
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1. INTRODUCTION
In shotgun proteomics, a complex protein mixture derived from a biological sample is directly analyzedvia a sequence of experimental and computational procedures (Aebersold and Mann, 2003; McDonald
and Yates, 2003; Kislinger and Emili, 2005; Swanson and Washburn, 2005). After protease digestion,
liquid chromatography (LC) coupled with tandem mass spectrometry (MS/MS) is typically used to separate
and fragment peptides from the sample, resulting in a number of MS/MS spectra. These spectra are subse-
quently searched against a protein database to identify peptides present in the sample (Marcotte, 2007;
Nesvizhskii, 2007). Many peptide search engines have been developed, among which Sequest (Yates et al.,
1995), Mascot (Perkins et al., 1999), and X!Tandem (Craig and Beavis, 2004) are commonly used. However,
after a reliable set of peptides is identified, it is often not straightforward to assemble a reliable list of proteins
from these peptides. This occurs because some identified peptides, referred to as the degenerate peptides, are
shared by two or more proteins in the database. As a result, the problem of determining which of the proteins
are indeed present in the sample, known as the protein inference problem (Nesvizhskii and Aebersold, 2005),
often has multiple solutions and can be computationally intractable. Nesvizhskii et al. (2003) first addressed
this challenge using a probabilistic model, but different problem formulations and new solutions have
recently been proposed as well (Nesvizhskii and Aebersold, 2005; Alves et al., 2007; Zhang et al., 2007).
Previously, we introduced a combinatorial approach to the protein inference problem that incorporates
the concept of peptide detectability, i.e., the probability of a peptide to be detected (identified) in a standard
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proteomics experiment, with the goal of finding the set of proteins with the minimal number of missed
peptides (Alves et al., 2007). As in the other combinatorial formulations (Zhang et al., 2007), the parsimony
condition was chosen only for convenience reasons, without theoretical justification. Furthermore, parsi-
monious formulations often lead to the minimum cover set problem, which is NP-hard. Thus, heuristic
algorithms following greedy (Alves et al., 2007) or graph-pruning strategies (Zhang et al., 2007) are used to
solve the protein inference problem without performance guarantee.
In this article, we address protein inference by proposing a novel Bayesian approach that takes as input a
set of identified peptides from any peptide search engine, and attempts to find a most probable set of proteins
from which those identified peptides originated. We considered two Bayesian models in our approach. The
basic model assumes that all identified peptides are correct, whereas the advanced model also accepts
the probability of each peptide to be correctly identified in the sample by spectrummatching. Compared with
the previous probabilistic models, such as ProteinProphet (Nesvizhskii et al., 2003), both of our models differ
in two key aspects. First, our approach incorporates the prior probability of peptide identification (Tang et al.,
2006), since it has been recently shown that even among the peptides that belong to the same protein, some
peptides are commonly observed, while some others are not (Tang et al., 2006; Lu et al., 2007). This results in
the fact that the peptides not identified by peptide search engines may have significant impact on the final
solution. Second, we devise a rigorious model to incorporate dependences between the identification of
peptides in the computation of the protein posterior probabilities and adopt a Gibbs sampling approach to
estimate them. The results of this study provide evidence that our models achieve satisfactory accuracy and
can be readily used in protein identification.
2. METHODS
To illustrate the challenge of protein inference, we define the protein configuration graph (Fig. 1a), i.e., a
bipartite graph in which two disjoint sets of vertices represent the proteins in the database and the peptides
from these proteins, respectively, and where each edge indicates that the peptide belongs to the protein. We
emphasize that the protein configuration graph is independent of the proteomics experiment, and thus can
be built solely from a set (database) of protein sequences. Therefore, in constrast to the bipartite graph used
previously (Zhang et al., 2007), where only the identified peptides and the proteins that contain those
peptides were represented, our model also considers the non-identified peptides. A protein configuration
graph is partitioned into connected components, each representing a group of proteins (e.g., homologous
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FIG. 1. (a) A protein configuration graph consisting of two connected components. (b) Basic Bayesian model for
protein inference, in which peptides are represented as a vector of indicator variables: 1 (gray) for identified peptides,
and 0 (white) for non-identified peptides. (c) Advanced Bayesian model for protein inference, in which each peptide is
associated to an identification score (0 for non-identified peptides). Sizes of circles reflect prior/posterior probabilities.
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proteins) sharing one or more (degenerate) peptides. If there are no degenerate peptides in the database,
each connected component will contain exactly one protein and its peptides. In practice, however, the
protein configuration graph may contain large connected components, especially for protein databases of
higher animals or those containing closely related species.
Given that the protein configuration graph can be interpreted as a Bayesian network with edges pointing
from proteins into peptides, it is straightforward to show that protein inference can be addressed separately
for each individual connected component. In this approach, the peptide identification results are first
mapped to the protein configuration graph. We use a vector of indicator variables (y1, . . . , yj, . . . , yn),
referred to as the peptide configuration, to denote a set of identified peptides. Given the peptide config-
uration, the protein configuration graph can be simplified by removing proteins containing no identified
peptides. We note, after the simplification, one connected component in the original protein configuration
graph may be partitioned into several small components. A connected component is called trivial if it
contains no identified peptides. Clearly, in this case protein inference is simple—none of the proteins
should be present in the sample. Therefore, the protein inference problem can be reduced to finding the
most likely protein configuration (x1, . . . , xi, . . . , xm) by analyzing non-trivial components only. In the
basic model, all identified peptides are assigned equal probabilities (¼ 1) (Fig. 1b), whereas in the advanced
model different probabilities are considered for different identified peptides depending on the associated
identification scores (s1, . . . , sj, . . . , sn) (Fig. 1c). Notation and definitions used in this study are summa-
rized in Table 1.
2.1. Basic Bayesian model
The basic model can be considered as a special case of the advanced model, in which the probabilities rj
for different peptides j are limited to 0 (for non-idenfitied peptides) or 1 (for identified peptides). We first
describe the basic model that formalizes the protein inference problem illustrated above, and will extend it
to the advanced model in the next section. In practice, the basic model can be used if the probabilities rj are
not provided, while the identified peptides are obtained at a stringent false discovery rate (FDR), e.g., 0.01,
by either a heuristic target-decoy search strategy (Elias et al., 2005; Zhang et al., 2007; Elias and Gygi,
2007) or by probabilistic modeling of random peptide identification scores (Keller et al., 2002; Wu et al.,
2006; Bern and Goldberg, 2007). In the next section, we extend this basic model to a more realistic model
in which we incorporate different probabilities for different identified peptides that are estimated based on
the peptide identification scores. When the probabilities of identified peptides are available, we expect the
advanced model should perform better than the basic model.
Let us now consider m proteins and n peptides from these proteins within a non-trivial connected
component of the protein configuration graph. Each protein i is either present in the sample or absent from
it, which can be represented by an indicator variable xi. Therefore, any solution of the protein inference
problem corresponds to a vector of indicator variables, (x1, . . . , xm), referred to as a protein configuration.
Given the set of identified peptides from peptide search engines (peptide configuration (y1, . . . , yn)), our
Table 1. Notations and Definitions
Notation Definition
(1, . . . , i, . . . ,m) m proteins within a non-trivial connected component of the protein configuration graph
(x1, . . . , xi, . . . , xm) protein configuration: indicator variables of proteins’ presences
(1, . . . , j, . . . , n) all n peptides from m proteins being considered
(Z11, . . . , Zij, . . . , Zmn) indicator variables of peptide j belonging to protein i if peptide j is a peptide from
protein i, Zij¼ 1; otherwise Zij¼ 0
(y1, . . . , yj, . . . , yn) peptide configuration: indicator variables of peptides’ presences if peptide j is present,
yj¼ 1; otherwise yj¼ 0
(s1, . . . , sj, . . . , sn) assigned scores of peptides if peptide j is not identified, sj¼ 0
(r1, . . . , rj, . . . , rn) probabilities of peptides being correctly identified also the estimated probabilities of
peptides’ presences
(LR1, . . . , LRj, . . . , LRn) likelihood ratio between peptides’s presences and absences
(d11, . . . , dij, . . . , dmn) prior probabilities of peptides to be identified from proteins if Zij¼ 1, dij¼ the
detectability of peptide j from protein i; otherwise, dij¼ 0
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goal is to find the maximum a posteriori (MAP) protein configuration, that is the configuration that
maximizes the posterior probability P(x1, . . . , xmjy1, . . . , yn),
(x1, . . . , xm)MAP¼ argmax(x1, ..., xm)P(x1, . . . , xmjy1, . . . , yn) (1)
Using Bayes’ rule, the posterior probability can be expressed as
P(x1, . . . , xmjy1, . . . , yn)¼ P(x1, . . . , xm)P(y1, . . . , ynjx1, . . . , xm)P
(x1, ..., xm)
[P(x1, . . . , xm)P(y1, . . . , ynjx1, . . . , xm)]
¼ P(x1, . . . , xm)
Q
j [1Pr(yj¼ 1jx1, . . . , xm)]1 yjPr(yj¼ 1jx1, . . . , xm)yjP
(x1, ..., xm)
P(x1, . . . , xm)
Q
j [1Pr(yj¼ 1jx1, . . . , xm)]1 yjPr(yj¼ 1jx1, . . . , xm)yj
(2)
where P(x1, . . . , xm) is the prior probability of the protein configuration. Assuming the presence of each
protein i is independent of other proteins, this prior probability can be computed as
P(x1, . . . , xm)¼
Y
i
P(xi) (3)
Pr(yj¼ 1jx1, . . . , xm) is the probability of peptide j to be identified by shotgun proteomics given the protein
configuration (x1, . . . , xm). Assuming that different proteins contribute independently to the identification
of a peptide, we can compute it as
Pr(yj¼ 1jx1, . . . , xm)¼ 1
Y
i
[1 xiPr(yj¼ 1jxi¼ 1, x1¼ . . . ¼ xi 1¼ xiþ 1¼ . . . ¼ xm¼ 0)] (4)
where Pr(yj¼ 1jxi¼ 1, x1¼ . . . ¼ xi 1¼ xiþ 1¼ . . . ¼ xm¼ 0) is the probability of peptide j to be identi-
fied if only protein i is present in the sample. As we previously showed, for a particular proteomics platform
(e.g., LC-MS/MS considered here), this probability, referred to as the standard peptide detectability dij, is
an intrinsic property of the peptide (within its parent protein), and can be predicted from the peptide and
protein sequence prior to a proteomics experiment (Tang et al., 2006). Combining equations 2–4, we can
compute the posterior probabilities for protein configurations as
P(x1, . . . , xmjy1, . . . , yn)¼
Q
i P(xi)
Q
jf[
Q
i (1 xidij)]1 yj[1
Q
i (1 xidij)]yjgP
(x0
1
, ..., x0m)
Q
i P(x
0
i)
Q
jf[
Q
i (1 x0idij)]1 yj[1
Q
i (1 x0idij)]yjg
(5)
Sometimes, we are also interested in the marginal posterior probability of a specific protein i to be
present in the sample, which can be expressed as,
P(xijy1, . . . , yn)¼
X
x1, ..., xi 1, xiþ 1, ..., xm
P(x1, . . . , xmjy1, . . . , yn) (6)
2.2. Advanced Bayesian model
The basic model described above requires that all identified peptides have equal probability (¼ 1) of
being correctly identified. Here we relax this assumption by introducing into the model a peptide identi-
fication score sj for each peptide j, which is the output of the peptide search engines. We assume the peptide
identification score is highly correlated with the probability of a peptide being correctly identified and their
relationship (denoted by rj¼Pr(yj¼ 1jsj)) can be approximately modeled using probabilistic methods
adopted by some search engines such as Mascot (Perkins et al. (1999)) or post-processing tools such as
PeptideProphet (Keller et al. (2002)). Our goal is to compute P(x1, . . . , xmjs1, . . . , sn) by enumerating all
potential peptide configurations
P(x1, . . . , xmjs1, . . . , sn)¼
X
(y1, ..., yn)
[P(x1, . . . , xmjy1, . . . , yn)P(y1, . . . , ynjs1, . . . , sn)]
¼
X
(y1, ..., yn)
P(x1, . . . , xm)
P(s1, . . . , sn)
P(y1, . . . , ynjx1, . . . , xm)P(s1, . . . , snjy1, . . . , yn)
  (7)
Assuming that sj is independent of the presences of the other peptides (i.e. (y1, . . . , yj 1, yjþ 1, . . . , yn))
for each peptide j, we have
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P(s1, . . . , snjy1, . . . , yn)¼
Y
j
P(sjjyj) (8)
and applying Bayes’ rule, we have
P(s1, . . . , snjy1, . . . , yn)¼
Y
j
P(yjjsj)P(sj)
P(yj)
¼
Y
j
(1 rj)(1 yj)ryjj P(sj)
P(yj)
(9)
where the marginal probability of a peptide j can be computed as
P(yj)¼
X
(x1, ..., xm)
[P(yjjx1, . . . , xm)P(x1, . . . , xm)]
¼ 1
Y
i
(1Pr(xi¼ 1)dij)
h iyj Y
i
(1Pr(xi¼ 1)dij)
h i(1 yj) (10)
Combining these equations, we can compute the posterior probability of protein configurations as
P(x1, . . . , xmjs1, . . . , sn)¼
P
(y1, ..., yn)
Q
i P(xi)
Q
j

[
Q
i (1 xidij)]1 yj[1
Q
i (1 xidij)]yj
(1 rj)(1 yj)ryjj
P(yj)

P
(x01, ..., x0m)(y1, ..., yn)
Q
i P(x0i)
Q
j

[
Q
i (1 x0idij)]1 yj [1
Q
i (1 x0idij)]yj
(1 rj)(1 yj)ryjj
P(yj)
 (11)
If we do not assume any prior knowledge about the protein presence in the sample, we can set
Pr(xi)¼ 0.5 in equations 5 and 11. In practice, prior knowledge, such as the species which the sample is
from, the number of candidate proteins, and known protein relative quantities or protein families that are
likely present in the sample, can be directly integrated into our Bayesian models. In the result section, we
demonstrate this by applying Pr(xi¼ 1)¼ T /N to all candidate proteins, where T is the estimated number
of actual proteins in the sample, and N is the total number of candidate proteins in the database containing
at least one identified peptide (Table 2).
Similarly, as in the basic model, we can also compute the posterior probability of a specific protein
i present in the sample as
P(xijs1, . . . , sn)¼
X
x1, ..., xi 1, xiþ 1, ..., xm
P(x1, . . . , xmjs1, . . . , sn) (12)
and the marginal posterior probability of a peptide j as
P(yjjs1, . . . , sn)¼
X
(x1, ..., xm;y1, ..., yj 1, yjþ 1, ..., yn)
[P(x1, . . . , xmjy1, . . . , yn)P(y1, . . . , ynjs1, . . . , sn)] (13)
2.3. Adjustment of peptide detectabilities
An adjustment of the predicted peptide detectabilities is necessary when applying them here, since the
predicted standard peptide detectabilities (denoted as d0ij) reflect the detectability of a peptide under a
standard proteomics experimental setting, in particular, under fixed and equal abundances (i.e. q0) for all
Table 2. Number of MS/MS Spectra, Candidate Peptides, Candidate Proteins,
and True Proteins in Each of the Three Sigma49 Datasets
Experiment No. of spectra
No. of candidate
peptides
No. of candidate
proteins
Estimated nos.
of true proteins
No. of proteins
for detectability
training Protein prior
1 5297 739 514 55 25 55/514
2 5155 684 481 55 22 55/481
3 5034 626 393 50 19 50/393
The peptides with Peptide-Prophet probability >0.05 were considered as candidate peptides, and the proteins containing at least one
candidate peptide were considered as candidate proteins. The number of true proteins is estimated by a preliminary run of the Bayesian
inference algorithm. Protein prior represents the prior probabilities of proteins used in the Bayesian model.
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proteins (Tang et al., 2006). Assuming that the abundance of protein i in the sample mixture is qi instead of
q0, the effective detectability of peptide j from this protein should be adjusted to
dij¼ 1 (1 d0ij)qi / q
0
(14)
Although we do not know qi explicitly, since the probability of a peptide j being correctly identified is
given by rj (or yj for basic model), we can estimate qi by solving the equation
P
j dij¼
P
j Zijrj for a specific
protein i. We note that this adjustment method may immediately lead to a new approach to absolute protein
quantification (Lu et al., 2007). However, we will address the evaluation of its performance in our future
work. Here, our goal is to utilize it to adjust the predicted standard peptide detectabilities based on the
estimated protein abundances.
2.4. Gibbs sampling
Given a protein configuration graph, the peptide detectabilities (dij), and the probabilities of peptides
being correctly identified (rj), the posterior distribution of protein configurations can be computed directly
from equations 5 or 11, depending on which Bayesian model is used. This brute force method, which has
computational complexity of O(2m) (for the basic model) or O(2mþn) (for the advanced model), is very
expensive and only works for small connected components in the protein configuration graph.
Gibbs sampling is a commonly used strategy to approximate a high-dimensional joint distribution that is
not explicitly known (Geman and Geman, 1984; Liu, 2002). We adopted this algorithm to achieve the
optimal protein configuration with the MAP probability. The original Gibbs sampling algorithm considers
one individual variable at a time in the multi-dimentional distribution. It, however, often converges slowly
and is easily trapped by local maxima for long time. Several techniques have been proposed to improve the
search efficiency of Gibbs sampling algorithm, such as random sweeping, blocking, and collapsing (Liu,
2002). Because in our case each variable xi to be sampled has small search space (i.e., {0,1}), we applied
Algorithm 1 Gibbs sampler for protein inferencing using the advanced model
Input : Probabilities of correct peptide identification (r1, . . . , rn) and peptide
detectabilities {dij}
Output :MAP protein configuration (x1, . . . , xm)
Initialize (x1, . . . , xm) and (y1, . . . , yn) randomly;
MaxPr  0;
while not converge do
c a random number between 0 and t;
(v1, . . . , vc) a random c-block from (1, . . . ,m);
d  t c;
(w1, . . . ,wd) a random d-block from (1, . . . , n);
Compute normalizing factor T  Value(x1, ..., xm ;y1, ..., yn)
F(xv1 , ..., xvc , yw1 , ..., ywd )
;
#Note: for the 1st iteration, set T  1;
for all (xv1 , . . . , xvc ) and (yw1 , . . . , ywd ) do
Compute F(xv1 , . . . , xvc ; yw1 , . . . , ywd );
memorizing: Value(x1, . . . , xm, y1, . . . , yn) F ·T ;
if Value(x1, . . . , xm, y1, . . . , yn)4MaxPr then
MaxPr  Value(x1, . . . , xm, y1, . . . , yn);
(xMax1 , . . . , x
Max
m ) (x1, . . . , xm);
(xMaxv1 , . . . , x
Max
vc
) (xv1 , . . . , xvc );
(yMax1 , . . . , y
Max
n ) (y1, . . . , yn);
(yMaxw1 , . . . , y
Max
wd
) (yw1 , . . . , ywd );
end
end
Sample (x0v1 , . . . , x
0
vc
; y0w1 , . . . , y
0
wd
) from normalized F(xv1 , . . . , xvc ; yw1 , . . . , ywd );
(xv1 , . . . , xvc ) (x0v1 , . . . , x0vc );
(yw1 , . . . , ywd ) (y0w1 , . . . , y0wd );
end
Report MaxPr, (xMax1 , . . . , x
Max
m ), and compute marginal probabilities;
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the block sampling technique in our Gibbs sampler algorithm (Algorithm 1). Without increasing the
computational complexity, we adopt a novel memorizing strategy that keeps a record of all (as well as the
maximum) posterior probabilities (and the corresponding protein configurations) among all configura-
tions we evaluated during the sampling procedure, and report the maximum solution in the end. The
memorized posterior probabilities are also used to calculate the marginal posterior protein probabilities in
equations 6, 12, and 13. We sketched the block Gibbs sampling algorithms and the memorizing approach in
Algorithm 1 for the advanced Bayesian model. A similar but simplified Gibbs sampling algorithm can be
used for the basic Bayesian model.
In these two algorithms discussed here, we have the following:
F(xv1 , . . . , xvc , yw1 , . . . , ywd )¼
Y
i2v
P(xi)
Y
j2N þ (v)[w
P(yjjxN  (j))
Y
j2w
P(yjjsN þ (j))
P(yj)
(15)
where Nþ(.) represents the set of peptide nodes in the protein configuration graph that the current protein
node (.) is linked, whereas N(.) represent the set of protein nodes that the current peptide node (.) is
linked; v¼fv1, . . . , vcg and w¼fw1, . . . ,wdg are the indeces of blocks for protein x and peptide y,
repectively. For the basic model, the set of blocks w is empty (or d¼ 0). Hence, P(yjjxN  (j)) can be
computed by equation 4, and Pr(yj¼ 1jsN þ (j)) are set to rj.
2.5. Datasets
We used three datasets from replicated LC/MS/MS analysis of a synthetic mixture of 49 standard
proteins (called Sigma49), which was made available by Sigma Corporation for the assessment of protein
analysis protocols. Tandem mass spectra of all three experiments were downloaded from the website at
Vanderbilt University (Zhang et al., 2007).
3. RESULTS
As in Zhang et al. (2007), prior to the protein inference, the MS/MS spectra acquired from Sigma49
sample in one LC/MS experiment were searched against the human proteome in Swiss-Prot database
(version 54.2). PeptideProphet (Keller et al., 2002) was then used to assign a probability score for each
identified peptide. To compute the peptide detectability, we trained separate predictors (neural networks)
for each of three experiments. For each experiment, a protein is included in the training set only if (1) it
contains at least two confidently identified peptides (i.e., PeptideProphet probability >0.95); and (2) it does
not share any identified peptide (with PeptideProphet probability >0.05) with other proteins. The positive
(detected) and negative (non-detected) training sets were composed of peptides from these proteins with
PeptideProphet probability >0.90 and <0.10, respectively. The remaining peptides (with PeptideProphet
probability between 0.1 and 0.9) were not used for training. To incorporate the changes of detectability due
to the variation of protein abundances, we employed the quantity adjustment method described in previ-
ous section to obtain the standard peptide detectability, which is presumably equivalent to the detectability of
a peptide at the standard abundance. After the predictors were trained, we used them to compute the standard
detectabilities for all tryptic peptides from all proteins, which were subsequencely used in the Bayesian
inference algorithms. Table 2 shows the details of the training datasets for each of the three experiments.
To set the probability rj for each peptide identification, we first converted the PeptideProphet probability
into a likelihood ratio LRj: LRj¼PrPP(yj¼ 1)/[c · (1PrPP(yj¼ 1))], where PrPP (yj¼ 1) is the Peptide-
Prophet probability, and c is the ratio between the prior probabilities of the peptide’s presence and absence;
and then converted LRj to rj: rj¼ LRj · dj/(LRj · djþ (1 dj)). For both models, we used block size 3 in the
Gibbs sampler.
In the extended abstract of this work presented at RECOMB meeting (Li et al., 2008), we have compared
the protein inference performances of the basic and advanced Bayesian models with that from Protein-
Prophet (Nesvizhskii et al., 2003) and the minimum missed peptide (MMP) approach we proposed pre-
viously (Alves et al., 2007) on the set of peptides identified using þ2 precursor ions in Sigma49 sample.
We concluded that the advanced Bayesian model gives better results than the basic model and previous
published methods. We also showed the adjustment of peptide quantity and the incorporation of expected
number of proteins into the protein prior estimation can improve the performance of protein inference. Here
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we extended our model in order to utilize all identified peptides regardless of their charge states. We note
that all details of our model remain the same except that the detectability of a peptide is redefined as the
probability of identifying this peptide as þ1, þ2 or þ3 charged ions instead of þ2 charged ions only in our
previous model. We implemented the advanced Bayesian model accordingly with estimated protein priors
(see the rightmost column in Table 2) and compared its results with ProteinProphet.
Sigma49 protein mixture sample were made by mixing 49 human proteins. However, repeated pro-
teomics experiments confirmed the existence of many contaminant proteins in the mixture. In the three
replicated LC/MS data sets, we analyzed here, 46 out of the 49 proteins were identified by at least one
peptide with PeptideProphet probability >0.05 (see the leftmost column in Table 3). Table 3 shows the
comparison between the results of ProteinProphet and that of the Bayesian inference model. It can be
observed that Bayesian inference model outperforms ProteinProphet by reporting more true positive pro-
teins, less false positive proteins and less false negative proteins in each of the three datasets.
As mentioned in the methods section, the Bayesian inference model can also be used to calculate a
posterior probability for each identified peptide (equation 13). This probability can be viewed as a re-
evaluation of the possibility of each peptide identification being correct, taking into account not only the
quality of the matching between the peptide and the MS/MS spectrum, but also the relationship among
peptides (and their matching with the corresponding MS/MS spectra) from the same protein. Therefore, it
should be a better way to assess the correctness of the peptide identification given a single LC/MS/MS
experiment as a whole. Figure 2 shows the precision-recall curves for the peptide identification using
posterior probabilities and the PeptideProphet probabilities that are used as input to Bayesian inference. On
average, the posterior Bayesian inference can improve the accuracy of the peptide identification by ap-
proximately 6% for the Sigma49 datasets (Table 4).
4. DISCUSSION
In this study, we proposed and evaluated a new methodology for protein inference in shotgun pro-
teomics. The Bayesian approach proposed herein attempts to find the set of proteins that is most likely to be
present in the sample. The new approach has several advantages over the existing methods: (1) it calculates
or, if the global optimum is not reached, approximates a MAP solution for the set of proteins present in the
sample and can also output the marginal posterior probability of each protein to be present in the sample;
(2) it can output the marginal posterior probabilities of the identified peptides to be correct, given the entire
experiment; (3) the Gibbs sampling approach used to approximate the posterior probabilities of protein
configuration is a proven methodology, and its performance and convergence has been well-studied; and (4)
our probabilistic models are based on clear assumptions, thus can be readily extended further.
It is common in proteomics for a sample to be analyzed multiple times in order to increase coverage of
the proteome as well as to increase confidence in low sequence coverage proteins (Brunner et al., 2007).
While not specifically addressed, the application of the Bayesian models described here adequately
Table 3. Protein Inference Results on Three Sigma49 Dataset Using ProteinProphet (PP)
and Bayesian Inference Model (BI)
Experiment
No. of identified
true proteins
TP FP FN F-measure
PP BI PP BI PP BI PP BI
1 46/60 40.5/46.5 46/49 9.5/3.5 9/1 8.5/36.6 3/34 0.82/0.70 0.89/0.74
2 46/59 42.8/49.8 44/50 14.2/7.2 11/5 6.2/33.2 5/33 0.81/0.71 0.85/0.73
3 46/57 41.8/47.8 43/49 7.2/1.2 7/1 7.2/35.2 6/34 0.85/0.73 0.87/0.74
All results are evaluated based on the true positive (TP), false positive (FP) and false negative (FN) numbers of proteins, and and
F-measure (F) in two categories of true proteins in the sample: model (49) proteins, and model proteins plus all contaminations (83 in
total). The total number of identified true proteins (i.e., with at least one peptide hit of PeptideProphet probability >0.05) in these two
categories are shown in the second column. MAP solutions were used as positive proteins for our probabilistic models; and 0.5 cutoff
was used for ProteinProphet. ProteinProphet may report a group of undistinguishable proteins. Here we assigned an equal fraction
value to each member in such group. As a result, some fractional values were assigned to TP/FP/FN protein numbers for
ProteinProphet.
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FIG. 2. Precision-recall curves of the peptide identification using posterior probabilities by Bayesian inference (light
curves, denoted as BI in the figure legend) and the PeptideProphet probabilities (dark curves) for the Sigma49 datasets 1
(a), 2 (b), and 3 (c).
accommodates such data since peptide detectability, used as prior probabilities to estimate the probabilities
of identified peptides, should assign lower values to those peptides not identified in all the replicate
analyses. In addition, higher mammalian proteomes often contain multiple very similar homologous pro-
teins due to recent gene duplications. Using existing protein inference algorithms, these proteins are
frequently impossible to differentiate using shotgun proteomics, if some but not all of these proteins are
present in the sample. We approached the problem by utilizing the different sets of tryptic peptides (and
their detectabilities) among homologous proteins, including both the identified and non-identified peptides.
Notably, although the MAP solution of the protein inference problem often reports the actual proteins (with
relatively higher posterior probabilities then the other candidate proteins), they each may receive a low
marginal posterior probability (e.g., <0.5). While we have not explicitly addressed this problem here, we
note that the proposed models can easily treat a given set of proteins as a group and then compute the
probability of their presence as a whole. We will test this functionality in future implementation of the
models.
The peptide detectability is originally defined as a probability of a peptide to be identified in a standard
shotgun proteomics experiment, in which all peptides are of equal abundances. To accommodate this
definition, we originally trained the detectability predictor using a standard protein mixture (Tang et al.,
2006). As a result, the predicted detectabilities may not be accurate for those peptides with very high or low
abundances. Since the detectability of each peptide should be based on the abundance at which each peptide
is present in the sample, we used estimated protein abundance values to adjust detectability both during the
training and the protein inference. As a result, the inference results from our current Bayesian models not
only report the presence of a protein, but also its abundance relative to the abundance of the standard
proteomics experiment, even though in this article we only analyzed the first part of the results.
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